RSSCategory: Pharmaceuticals

Nuvilex Announces Further Enhancement of Patent Position

April 12, 2012

SINGAPORE – Nuvilex, Inc., through its Singapore-based biotech company associate, SG Austria, announced completion of substantial therapeutic antibody patent portfolio talks, culminating in the addition of the Exclusive Worldwide License to the existing SG Austria patent position for encapsulating therapeutic […]

Continue Reading

Cancer-agent found in Japan weight loss pills

April 5, 2012

The US Food and Drug Administration on Tuesday warned consumers not to take a product called “Japan Rapid Weight Loss Diet Pills” because they contain a suspected cancer-causing agent. The pills, advertised as promoting weight loss, are distributed by a […]

Continue Reading

Babies treated in the womb for obesity

April 2, 2012

UNITED KINGDOM – More than 400 pregnant moms will take anti-obesity pills in a new study aimed at creating smaller babies and lowering the risk for Caesarean sections. The three-year study will be completed at the Liverpool Women’s Hospital in […]

Continue Reading

Unsupervised protein shake consumption can be harmful

April 2, 2012

Nutritionists in Canada are warning teenagers to stay away from protein powders and pre-mixed supplement drinks that may have unregulated ingredients, and may end up just making them ill or fat. Dietician Ashley Charlebois said health and muscle-conscious teenagers might […]

Continue Reading

Diet drugs make second bid for FDA approval

March 31, 2012

Despite the latest rejections, two drug makers are resubmitting their products for a second review. Orexigen Therapeutics’ Contrave and Arena’s Lorcaserin are hoping to receive favourable decisions from the Food and Drug Administration. | Diet Health Care Asia Home Despite […]

Continue Reading

Mutated gene weakens cancer-fighting drugs

March 31, 2012

Researchers have discovered why some anti-cancer drugs become less effective. They have found a mutation in a gene that makes some cancer drugs less effective, as well as a solution to tackle this problem. Led by Assoc. Prof. Ong Sin […]

Continue Reading

Qnexa awaits FDA green light

March 31, 2012

If the odds be ever in their favour, Qnexa could be the first new obesity drug to receive Food and Drug Administration (FDA) approval in 13 years. The last was Xenical that hit the market in 1999. Last February, a […]

Continue Reading